NCT04521686 2026-04-22Study of LY3410738 Administered to Patients With Advanced Solid Tumors With IDH1 or IDH2 MutationsEli Lilly and CompanyPhase 1 Active not recruiting200 enrolled
NCT06840886 2026-04-22A Study of PHST001 in Advanced Solid TumorsPheast TherapeuticsPhase 1 Recruiting272 enrolled